Crossmark Global Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
|
|||||
|
2025
Q1 | $2.99M | Sell |
|
|||||
|
2024
Q4 | $2.5M | Buy |
|
|||||
|
2024
Q3 | $2.73M | Sell |
|
|||||
|
2024
Q2 | $2.89M | Sell |
|
|||||
|
2024
Q1 | $2.59M | Sell |
|
|||||
|
2023
Q4 | $3.45M | Buy |
|
|||||
|
2023
Q3 | $2.9M | Buy |
|
|||||
|
2023
Q2 | $2.39M | Buy |
|
|||||
|
2023
Q1 | $2.1M | Sell |
|
|||||
|
2022
Q4 | $2.75M | Buy |
|
|||||
|
2022
Q3 | $2.64M | Buy |
|
|||||
|
2022
Q2 | $2.47M | Sell |
|
|||||
|
2022
Q1 | $2.35M | Buy |
|
|||||
|
2021
Q4 | $1.7M | Sell |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|
|||||
|
2021
Q2 | $1.6M | Sell |
|
|||||
|
2021
Q1 | $1.92M | Sell |
|
|||||
|
2020
Q4 | $2.2M | Sell |
|
|||||
|
2020
Q3 | $2.65M | Sell |
|
|||||
|
2020
Q2 | $7.25M | Buy |
|
|||||
|
2020
Q1 | $5.64M | Buy |
|
|||||
|
2019
Q4 | $5.14M | Sell |
|
|||||
|
2019
Q3 | $4.57M | Buy |
|
|||||
|
2019
Q2 | $4.94M | Buy |
|
|||||
|
2019
Q1 | $4.87M | Sell |
|
|||||
|
2018
Q4 | $4.46M | Sell |
|
|||||
|
2018
Q3 | $5.45M | Sell |
|
|||||
|
2018
Q2 | $4.98M | Sell |
|
|||||
|
2018
Q1 | $4.9M | Sell |
|
|||||
|
2017
Q4 | $4.88M | Buy |
|
|||||
|
2017
Q3 | $3.42M | Buy |
|
|||||
|
2016
Q3 | $3.42M | Buy |
|